Table of Content

1 Market Overview of RNA Medicine
1.1 RNA Medicine Market Overview
1.1.1 RNA Medicine Product Scope
1.1.2 RNA Medicine Market Status and Outlook
1.2 Global RNA Medicine Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global RNA Medicine Market Size by Region (2024-2034)
1.4 Global RNA Medicine Historic Market Size by Region (2024-2024)
1.5 Global RNA Medicine Market Size Forecast by Region (2024-2034)
1.6 Key Regions, RNA Medicine Market Size (2024-2034)
1.6.1 North America RNA Medicine Market Size (2024-2034)
1.6.2 Europe RNA Medicine Market Size (2024-2034)
1.6.3 Asia-Pacific RNA Medicine Market Size (2024-2034)
1.6.4 Latin America RNA Medicine Market Size (2024-2034)
1.6.5 Middle East & Africa RNA Medicine Market Size (2024-2034)
2 RNA Medicine Market by Type
2.1 Introduction
2.1.1 siRNA
2.1.2 ASO
2.1.3 miRNA
2.1.4 Nucleic Acid Aptamers
2.2 Global RNA Medicine Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global RNA Medicine Historic Market Size by Type (2024-2024)
2.2.2 Global RNA Medicine Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America RNA Medicine Revenue Breakdown by Type (2024-2034)
2.3.2 Europe RNA Medicine Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific RNA Medicine Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America RNA Medicine Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa RNA Medicine Revenue Breakdown by Type (2024-2034)
3 RNA Medicine Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Diabetes
3.1.3 Tuberculosis
3.1.4 Cardiovascular Diseases
3.1.5 Others
3.2 Global RNA Medicine Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global RNA Medicine Historic Market Size by Application (2024-2024)
3.2.2 Global RNA Medicine Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America RNA Medicine Revenue Breakdown by Application (2024-2034)
3.3.2 Europe RNA Medicine Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific RNA Medicine Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America RNA Medicine Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa RNA Medicine Revenue Breakdown by Application (2024-2034)
4 RNA Medicine Competition Analysis by Players
4.1 Global RNA Medicine Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Medicine as of 2022)
4.3 Date of Key Players Enter into RNA Medicine Market
4.4 Global Top Players RNA Medicine Headquarters and Area Served
4.5 Key Players RNA Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 RNA Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer RNA Medicine Products, Services and Solutions
5.1.4 Pfizer RNA Medicine Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche RNA Medicine Products, Services and Solutions
5.2.4 Roche RNA Medicine Revenue (US$ Million) & (2024-2024)
5.2.5 Roche Recent Developments
5.3 Sanofi-Aventis
5.3.1 Sanofi-Aventis Profile
5.3.2 Sanofi-Aventis Main Business
5.3.3 Sanofi-Aventis RNA Medicine Products, Services and Solutions
5.3.4 Sanofi-Aventis RNA Medicine Revenue (US$ Million) & (2024-2024)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories RNA Medicine Products, Services and Solutions
5.4.4 Abbott Laboratories RNA Medicine Revenue (US$ Million) & (2024-2024)
5.4.5 Abbott Laboratories Recent Developments
5.5 Arrowhead Pharmaceuticals
5.5.1 Arrowhead Pharmaceuticals Profile
5.5.2 Arrowhead Pharmaceuticals Main Business
5.5.3 Arrowhead Pharmaceuticals RNA Medicine Products, Services and Solutions
5.5.4 Arrowhead Pharmaceuticals RNA Medicine Revenue (US$ Million) & (2024-2024)
5.5.5 Arrowhead Pharmaceuticals Recent Developments
5.6 Benitec Biopharma
5.6.1 Benitec Biopharma Profile
5.6.2 Benitec Biopharma Main Business
5.6.3 Benitec Biopharma RNA Medicine Products, Services and Solutions
5.6.4 Benitec Biopharma RNA Medicine Revenue (US$ Million) & (2024-2024)
5.6.5 Benitec Biopharma Recent Developments
5.7 Calimmune Inc
5.7.1 Calimmune Inc Profile
5.7.2 Calimmune Inc Main Business
5.7.3 Calimmune Inc RNA Medicine Products, Services and Solutions
5.7.4 Calimmune Inc RNA Medicine Revenue (US$ Million) & (2024-2024)
5.7.5 Calimmune Inc Recent Developments
5.8 Dicerna
5.8.1 Dicerna Profile
5.8.2 Dicerna Main Business
5.8.3 Dicerna RNA Medicine Products, Services and Solutions
5.8.4 Dicerna RNA Medicine Revenue (US$ Million) & (2024-2024)
5.8.5 Dicerna Recent Developments
5.9 Gradalis
5.9.1 Gradalis Profile
5.9.2 Gradalis Main Business
5.9.3 Gradalis RNA Medicine Products, Services and Solutions
5.9.4 Gradalis RNA Medicine Revenue (US$ Million) & (2024-2024)
5.9.5 Gradalis Recent Developments
5.10 Quark
5.10.1 Quark Profile
5.10.2 Quark Main Business
5.10.3 Quark RNA Medicine Products, Services and Solutions
5.10.4 Quark RNA Medicine Revenue (US$ Million) & (2024-2024)
5.10.5 Quark Recent Developments
5.11 RXi
5.11.1 RXi Profile
5.11.2 RXi Main Business
5.11.3 RXi RNA Medicine Products, Services and Solutions
5.11.4 RXi RNA Medicine Revenue (US$ Million) & (2024-2024)
5.11.5 RXi Recent Developments
5.12 Senesco
5.12.1 Senesco Profile
5.12.2 Senesco Main Business
5.12.3 Senesco RNA Medicine Products, Services and Solutions
5.12.4 Senesco RNA Medicine Revenue (US$ Million) & (2024-2024)
5.12.5 Senesco Recent Developments
5.13 Silence Therapeutics
5.13.1 Silence Therapeutics Profile
5.13.2 Silence Therapeutics Main Business
5.13.3 Silence Therapeutics RNA Medicine Products, Services and Solutions
5.13.4 Silence Therapeutics RNA Medicine Revenue (US$ Million) & (2024-2024)
5.13.5 Silence Therapeutics Recent Developments
5.14 Silenseed
5.14.1 Silenseed Profile
5.14.2 Silenseed Main Business
5.14.3 Silenseed RNA Medicine Products, Services and Solutions
5.14.4 Silenseed RNA Medicine Revenue (US$ Million) & (2024-2024)
5.14.5 Silenseed Recent Developments
5.15 Tekmira
5.15.1 Tekmira Profile
5.15.2 Tekmira Main Business
5.15.3 Tekmira RNA Medicine Products, Services and Solutions
5.15.4 Tekmira RNA Medicine Revenue (US$ Million) & (2024-2024)
5.15.5 Tekmira Recent Developments
5.16 Alnylam Pharmaceuticals
5.16.1 Alnylam Pharmaceuticals Profile
5.16.2 Alnylam Pharmaceuticals Main Business
5.16.3 Alnylam Pharmaceuticals RNA Medicine Products, Services and Solutions
5.16.4 Alnylam Pharmaceuticals RNA Medicine Revenue (US$ Million) & (2024-2024)
5.16.5 Alnylam Pharmaceuticals Recent Developments
6 North America
6.1 North America RNA Medicine Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe RNA Medicine Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RNA Medicine Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RNA Medicine Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RNA Medicine Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RNA Medicine Market Dynamics
11.1 RNA Medicine Industry Trends
11.2 RNA Medicine Market Drivers
11.3 RNA Medicine Market Challenges
11.4 RNA Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market RNA Medicine Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global RNA Medicine Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global RNA Medicine Market Size Share by Region (2024-2024)
Table 4. Global RNA Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global RNA Medicine Forecasted Market Size Share by Region (2024-2034)
Table 6. Global RNA Medicine Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global RNA Medicine Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global RNA Medicine Revenue Market Share by Type (2024-2024)
Table 9. Global RNA Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global RNA Medicine Revenue Market Share by Type (2024-2034)
Table 11. North America RNA Medicine Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America RNA Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe RNA Medicine Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe RNA Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific RNA Medicine Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific RNA Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America RNA Medicine Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America RNA Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa RNA Medicine Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa RNA Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global RNA Medicine Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global RNA Medicine Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global RNA Medicine Revenue Market Share by Application (2024-2024)
Table 24. Global RNA Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global RNA Medicine Revenue Market Share by Application (2024-2034)
Table 26. North America RNA Medicine Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America RNA Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe RNA Medicine Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe RNA Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific RNA Medicine Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific RNA Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America RNA Medicine Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America RNA Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa RNA Medicine Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa RNA Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global RNA Medicine Revenue (US$ Million) by Players (2024-2024)
Table 37. Global RNA Medicine Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Medicine as of 2022)
Table 39. Date of Key Players Enter into RNA Medicine Market
Table 40. Global RNA Medicine Key Players Headquarters and Area Served
Table 41. RNA Medicine Product Solution and Service
Table 42. Global RNA Medicine Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer RNA Medicine Products, Services and Solutions
Table 47. Revenue (US$ Million) in RNA Medicine Business of Pfizer (2024-2024)
Table 48. Pfizer Recent Developments
Table 49. Roche Basic Information List
Table 50. Roche Description and Business Overview
Table 51. Roche RNA Medicine Products, Services and Solutions
Table 52. Revenue (US$ Million) in RNA Medicine Business of Roche (2024-2024)
Table 53. Roche Recent Developments
Table 54. Sanofi-Aventis Basic Information List
Table 55. Sanofi-Aventis Description and Business Overview
Table 56. Sanofi-Aventis RNA Medicine Products, Services and Solutions
Table 57. Revenue (US$ Million) in RNA Medicine Business of Sanofi-Aventis (2024-2024)
Table 58. Sanofi-Aventis Recent Developments
Table 59. Abbott Laboratories Basic Information List
Table 60. Abbott Laboratories Description and Business Overview
Table 61. Abbott Laboratories RNA Medicine Products, Services and Solutions
Table 62. Revenue (US$ Million) in RNA Medicine Business of Abbott Laboratories (2024-2024)
Table 63. Abbott Laboratories Recent Developments
Table 64. Arrowhead Pharmaceuticals Basic Information List
Table 65. Arrowhead Pharmaceuticals Description and Business Overview
Table 66. Arrowhead Pharmaceuticals RNA Medicine Products, Services and Solutions
Table 67. Revenue (US$ Million) in RNA Medicine Business of Arrowhead Pharmaceuticals (2024-2024)
Table 68. Arrowhead Pharmaceuticals Recent Developments
Table 69. Benitec Biopharma Basic Information List
Table 70. Benitec Biopharma Description and Business Overview
Table 71. Benitec Biopharma RNA Medicine Products, Services and Solutions
Table 72. Revenue (US$ Million) in RNA Medicine Business of Benitec Biopharma (2024-2024)
Table 73. Benitec Biopharma Recent Developments
Table 74. Calimmune Inc Basic Information List
Table 75. Calimmune Inc Description and Business Overview
Table 76. Calimmune Inc RNA Medicine Products, Services and Solutions
Table 77. Revenue (US$ Million) in RNA Medicine Business of Calimmune Inc (2024-2024)
Table 78. Calimmune Inc Recent Developments
Table 79. Dicerna Basic Information List
Table 80. Dicerna Description and Business Overview
Table 81. Dicerna RNA Medicine Products, Services and Solutions
Table 82. Revenue (US$ Million) in RNA Medicine Business of Dicerna (2024-2024)
Table 83. Dicerna Recent Developments
Table 84. Gradalis Basic Information List
Table 85. Gradalis Description and Business Overview
Table 86. Gradalis RNA Medicine Products, Services and Solutions
Table 87. Revenue (US$ Million) in RNA Medicine Business of Gradalis (2024-2024)
Table 88. Gradalis Recent Developments
Table 89. Quark Basic Information List
Table 90. Quark Description and Business Overview
Table 91. Quark RNA Medicine Products, Services and Solutions
Table 92. Revenue (US$ Million) in RNA Medicine Business of Quark (2024-2024)
Table 93. Quark Recent Developments
Table 94. RXi Basic Information List
Table 95. RXi Description and Business Overview
Table 96. RXi RNA Medicine Products, Services and Solutions
Table 97. Revenue (US$ Million) in RNA Medicine Business of RXi (2024-2024)
Table 98. RXi Recent Developments
Table 99. Senesco Basic Information List
Table 100. Senesco Description and Business Overview
Table 101. Senesco RNA Medicine Products, Services and Solutions
Table 102. Revenue (US$ Million) in RNA Medicine Business of Senesco (2024-2024)
Table 103. Senesco Recent Developments
Table 104. Silence Therapeutics Basic Information List
Table 105. Silence Therapeutics Description and Business Overview
Table 106. Silence Therapeutics RNA Medicine Products, Services and Solutions
Table 107. Revenue (US$ Million) in RNA Medicine Business of Silence Therapeutics (2024-2024)
Table 108. Silence Therapeutics Recent Developments
Table 109. Silenseed Basic Information List
Table 110. Silenseed Description and Business Overview
Table 111. Silenseed RNA Medicine Products, Services and Solutions
Table 112. Revenue (US$ Million) in RNA Medicine Business of Silenseed (2024-2024)
Table 113. Silenseed Recent Developments
Table 114. Tekmira Basic Information List
Table 115. Tekmira Description and Business Overview
Table 116. Tekmira RNA Medicine Products, Services and Solutions
Table 117. Revenue (US$ Million) in RNA Medicine Business of Tekmira (2024-2024)
Table 118. Tekmira Recent Developments
Table 119. Alnylam Pharmaceuticals Basic Information List
Table 120. Alnylam Pharmaceuticals Description and Business Overview
Table 121. Alnylam Pharmaceuticals RNA Medicine Products, Services and Solutions
Table 122. Revenue (US$ Million) in RNA Medicine Business of Alnylam Pharmaceuticals (2024-2024)
Table 123. Alnylam Pharmaceuticals Recent Developments
Table 124. North America RNA Medicine Market Size by Country (2024-2024) & (US$ Million)
Table 125. North America RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 126. Europe RNA Medicine Market Size by Country (2024-2024) & (US$ Million)
Table 127. Europe RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 128. Asia-Pacific RNA Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 129. Asia-Pacific RNA Medicine Market Size by Region (2024-2024) & (US$ Million)
Table 130. Asia-Pacific RNA Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 131. Asia-Pacific RNA Medicine Market Share by Region (2024-2024)
Table 132. Asia-Pacific RNA Medicine Market Share by Region (2024-2034)
Table 133. Latin America RNA Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 134. Latin America RNA Medicine Market Size by Country (2024-2024) & (US$ Million)
Table 135. Latin America RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 136. Middle East & Africa RNA Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 137. Middle East & Africa RNA Medicine Market Size by Country (2024-2024) & (US$ Million)
Table 138. Middle East & Africa RNA Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 139. RNA Medicine Market Trends
Table 140. RNA Medicine Market Drivers
Table 141. RNA Medicine Market Challenges
Table 142. RNA Medicine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Medicine Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global RNA Medicine Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global RNA Medicine Market Share by Regions: 2022 VS 2034
Figure 4. Global RNA Medicine Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America RNA Medicine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe RNA Medicine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific RNA Medicine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America RNA Medicine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa RNA Medicine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of siRNA
Figure 11. Global siRNA Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of ASO
Figure 13. Global ASO Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of miRNA
Figure 15. Global miRNA Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Nucleic Acid Aptamers
Figure 17. Global Nucleic Acid Aptamers Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global RNA Medicine Market Size Share by Type: 2022 & 2034
Figure 19. North America RNA Medicine Revenue Market Share by Type (2024-2034)
Figure 20. Europe RNA Medicine Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific RNA Medicine Revenue Market Share by Type (2024-2034)
Figure 22. Latin America RNA Medicine Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa RNA Medicine Revenue Market Share by Type (2024-2034)
Figure 24. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Diabetes Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Tuberculosis Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Cardiovascular Diseases Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Global RNA Medicine Market Size Share by Application: 2022 & 2034
Figure 30. North America RNA Medicine Revenue Market Share by Application (2024-2034)
Figure 31. Europe RNA Medicine Revenue Market Share by Application (2024-2034)
Figure 32. Asia-Pacific RNA Medicine Revenue Market Share by Application (2024-2034)
Figure 33. Latin America RNA Medicine Revenue Market Share by Application (2024-2034)
Figure 34. Middle East and Africa RNA Medicine Revenue Market Share by Application (2024-2034)
Figure 35. RNA Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 36. Global Top 5 and Top 10 Players RNA Medicine Market Share in 2022
Figure 37. North America RNA Medicine Market Share by Country (2024-2034)
Figure 38. United States RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 39. Canada RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 40. Germany RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 41. France RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 42. U.K. RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 43. Italy RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 44. Russia RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 45. Nordic Countries RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 46. Asia-Pacific RNA Medicine Market Share by Region (2024-2034)
Figure 47. China RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 48. Japan RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 49. South Korea RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 50. Southeast Asia RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 51. India RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 52. Australia RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 53. Latin America RNA Medicine Market Share by Country (2024-2034)
Figure 54. Mexico RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 55. Brazil RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 56. Middle East & Africa RNA Medicine Market Share by Country (2024-2034)
Figure 57. Turkey RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 58. Saudi Arabia RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 59. UAE RNA Medicine Market Size (2024-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report